Related references
Note: Only part of the references are listed.Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features
Giacomo Caio et al.
BMC GASTROENTEROLOGY (2019)
Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status
Maarit Ahtiainen et al.
MODERN PATHOLOGY (2019)
The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
Antje Tunger et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Landscape of Tumor Mutation Load, Mismatch RepairDeficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
Mohamed E. Salem et al.
MOLECULAR CANCER RESEARCH (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Primary small bowel adenomas and adenocarcinomas-recent advances
Aoife Maguire et al.
VIRCHOWS ARCHIV (2018)
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Ulrika A. Hanninen et al.
PLOS GENETICS (2018)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome
Gustaw Lech et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Genomic Profiling of Small-Bowel Adenocarcinoma
Alexa B. Schrock et al.
JAMA ONCOLOGY (2017)
PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis
Lihu Gu et al.
PLOS ONE (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?
Ramya Thota et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)
Immunoscore in mismatch repair-proficient and -deficient colon cancer
Erkki-Ville Wirta et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer
Kyu Sang Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Gastrointestinal cancers in inflammatory bowel disease: An update with emphasis on imaging findings
Matthias Barral et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
Yaqi Li et al.
MOLECULAR CANCER (2016)
The Role of Prostaglandin E-2 in Tumor-Associated Immunosuppression
Dingzhi Wang et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients
Marius Ilie et al.
VIRCHOWS ARCHIV (2016)
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
Genetic risks and familial associations of small bowel carcinoma
Santosh Shenoy
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Lifestyle factors and small intestine adenocarcinoma risk: A systematic review and meta-analysis
Caoimhe M. Bennett et al.
CANCER EPIDEMIOLOGY (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
Kurt A. Schalper et al.
CLINICAL CANCER RESEARCH (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment
Thomas Aparicio et al.
DIGESTIVE AND LIVER DISEASE (2014)
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes
Ching-Yao Yang et al.
EUROPEAN JOURNAL OF CANCER (2014)
Programmed death ligand-1 expression in non-small cell lung cancer
Vamsidhar Velcheti et al.
LABORATORY INVESTIGATION (2014)
Small bowel adenocarcinoma and Crohn's disease: Any further ahead than 50 years ago?
Caitlin Cahill et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Regional specialization within the intestinal immune system
Allan M. Mowat et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Dysplasia in inflammatory bowel diseases
Claudia Mescoli et al.
DIGESTIVE AND LIVER DISEASE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells
Sheng-Jia Shi et al.
PLOS ONE (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
Chuan-Yong Mu et al.
MEDICAL ONCOLOGY (2011)
Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
Zhen Zeng et al.
PLOS ONE (2011)
Tumor Cell Expression of Programmed Cell Death-1 Ligand 1 Is a Prognostic Factor for Malignant Melanoma
Ryosuke Hino et al.
CANCER (2010)
Clinical Significance of B7-H1 and B7-1 Expressions in Pancreatic Carcinoma
Liancai Wang et al.
WORLD JOURNAL OF SURGERY (2010)
The Epidemiology and Pathogenesis of Neoplasia in the Small Intestine
David Schottenfeld et al.
ANNALS OF EPIDEMIOLOGY (2009)
Small Bowel Cancer in the United States Changes in Epidemiology, Treatment, and Survival Over the Lost 20 Years
Karl Y. Bilimoria et al.
ANNALS OF SURGERY (2009)
Small-bowel tumors - Epidemiologic and clinical characteristics of 1260 cases from the Connecticut Tumor Registry
Ioannis Hatzaras et al.
ARCHIVES OF SURGERY (2007)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy
R. Houston Thompson et al.
CLINICAL CANCER RESEARCH (2007)
Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-γ-induced nitric oxide production
H Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Malignant complications of coeliac disease
N Brousse et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
Y Ohigashi et al.
CLINICAL CANCER RESEARCH (2005)
Pathogenesis and risk factors of small bowel adenocarcinoma: A colorectal cancer sibling?
T Delaunoit et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease
DD Potter et al.
CANCER RESEARCH (2004)
Share Paper
